The next generation of smart cell therapies using protein design and synthetic biology. Committed to mechanistic and structural understanding.
Joined February 2021
- Tweets 9
- Following 12
- Followers 332
- Likes 6
4 Photos and videos
23 Aug 2022
Congratulations to our Outpace bike riders for completing the 50mi course in the Fred Hutchinson Cancer Center's 10th annual #Obliteride - along with our 3 virtual participants. We are happy to support our colleagues to advance curative therapies for cancer and other diseases
5
Outpace Bio retweeted
28 Jun 2022
Please allow us to introduce ourselves - we are OpenFold openfold.io/, a consortium of life science & tech cos & academics democratizing AI for Biology. Founded by @MoAlQuraishi @ArzedaCo @cyrusbiotech @OutpaceBio @PrescientDesign help from @AWS businesswire.com/news/home/2…
14
259
1,195
22 Jun 2022
We're excited to contribute to OpenFold and work towards making the best ML-powered structural biology tools readily accessible and improved upon by community-driven efforts. Congrats to the AlQuraishi lab @MoAlQuraishi and OpenFold team on reaching this important milestone
22 Jun 2022
We have successfully trained OpenFold from scratch, our trainable PyTorch implementation of AlphaFold2. The new OpenFold (OF) (slightly) outperforms AlphaFold2 (AF2). I believe this is the first publicly available reproduction of AF2. We learned a lot. A🧵1/12
1
9
7 Jun 2022
Respect and Inclusion are the foundation of our culture at Outpace. We are proud to support our LGBTQ colleagues and recognize that our diversity is part of what makes us successful. Happy pride month from Outpace!
1
7
11 Nov 2021
Thanks to @NVIDIAHealth for the shoutout at GTC! Excited to continue our pioneering work in protein design for cell therapies. #GTC21
3
8
1 Sep 2021
A snapshot from our outdoor company lunch yesterday. It’s the contribution from each individual in this photo that makes Outpace such an awesome place to work!
1
1
20
6 Apr 2021
2
24
31 Mar 2021
We’re thrilled to announce our $30M Series A financing and collaboration with Lyell Immunopharma to make better immune cell therapies for the treatment of cancer. globenewswire.com/news-relea…
2
5
28
31 Mar 2021
We’re excited to be working with our lead investors, @ArtisVentures and Lyell Immunopharma, as well as @AbstractVC, @CivilizationVC, @Mubadala, @Playground_VC, @SahsenVentures, @wrfseattle. Welcome to the board, @vasudevbailey.
1
12